Wait Times: Behind every statistic there are patients suffering, says CMA
OTTAWA, ON, May 10, 2022 /CNW/ - The Canadian Institute for Health Information (CIHI) today published a new update on wait times during the first 18 months of the pandemic. In response, the Canadian Medical Association (CMA) reiterates the urgency of addressing backlogs in care and, most critically, of overhauling the health care system to prevent these consequences from recurring.
The effects of backlogs in procedures and treatments have a profound impact on patients and on the health care system at large. The repercussions will be felt for years to come, and it is important to devise a plan now to keep patients' conditions from worsening. Now is the time not only for provincial governments to make this a priority, but also for the federal government to provide the funding needed to bring wait times back down to a reasonable level.
We know that physicians across the country are doing everything in their power to care for their patients in a timely manner, and, for that, they have my deepest thanks. Let us not forget that, behind all these backlogs, there are people suffering. It is high time we took bold systemic action to finally give Canadians the care they deserve.
Dr. Katharine Smart President, Canadian Medical Association
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...
